Neuroprotective Efficacy of Fisetin Against VPA-Induced Autistic Neurobehavioral Alterations by Targeting Dysregulated Redox Homeostasis
- 1 June 2023
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 73 (6) , 403-422
Abstract
Autism is a neurodevelopmental condition, and it's associated pathophysiology, viz., oxidative stress and altered cellular homeostasis, has been extensively intertwined with behavioral impairments. Therefore, targeting oxidative stress and redox cellular homeostasis could be beneficial in relieving autistic-like symptoms. For this purpose, we examined a library of nutraceutical compounds that led us to a bioflavonoid fisetin. Autism-like neurobehavior was induced by subjecting the pregnant rodents to valproic acid at the time of neural tube closure (GD12.5). In this novel study, fisetin was evaluated for its neuroprotective potential at gestational (GD13 until delivery) and post-weaning developmental windows (PND 23–32) in VPA-induced rodent model of autism. Developmental VPA exposure increased intracellular ROS production, oxidative stress, altered AChE and ATPases in brain regions, and induced autistic-like behavioral impairments (social, repetitive, stereotyped, and sensorimotor). The present findings suggested that gestational and post-weaning fisetin treatment significantly improved the behavioral impairments by attenuating elevated oxidative stress, ROS, lipid peroxidation, and re-establishing redox homeostasis. Also, it effectively reinstated the reduced levels of endogenous antioxidants, glutathione, AChE, and ATPases by its antioxidant potential. Therefore, fisetin with its properties could be used as a potential therapeutic agent in overcoming the symptoms associated with autism. Graphical AbstractKeywords
Funding Information
- CSIR- New Delhi (09/135/2017 (790)-EMR-I)
This publication has 107 references indexed in Scilit:
- Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autismMolecular Autism, 2013
- General developmental health in the VPA-rat model of autismFrontiers in Behavioral Neuroscience, 2013
- Modeling autism: a systems biology approachJournal of Clinical Bioinformatics, 2012
- Automated Three‐Chambered Social Approach Task for MiceCurrent Protocols in Neuroscience, 2011
- Reactive Oxygen Species in the Regulation of Synaptic Plasticity and MemoryAntioxidants & Redox Signaling, 2011
- Fetal exposure to teratogens: Evidence of genes involved in autismNeuroscience & Biobehavioral Reviews, 2011
- Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individualsLife Sciences, 2009
- Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitorsBritish Journal of Pharmacology, 2008
- Regional difference of ROS generation, lipid peroxidaton, and antioxidant enzyme activity in rat brain and their dietary modulationArchives of Pharmacal Research, 1999
- Chromodacryorrhea in Rats: Absence Following Soman PoisoningToxicology and Applied Pharmacology, 1994